You have read all your free articles, to continue reading subscribe to read the rest of this content.
Together with LTS Lohmann Therapie-Systeme the company will start the first-ever clinical trial of microarray patches for the local intradermal treatment of psoriasis. The study will start in April 2019 with expected completion later this year and the aim of the study is to document safety and efAlready a subscriber…
The report The Swedish Drug Development Pipeline in 2014 highlights the 98 companies actively developing novel treatments. The projects analyzed are future products for human use that reached clinical development, Phase I-III. Data and information in this report originate from a web-based survey andAlready a subscriber Login You have read…
AstraZeneca and its global biologics research and development arm, MedImmune, has announced the results of the Phase III STRATOS 2 and TROPOS trials for tralokinumab, an anti-interleukin-13 (IL-13) human monoclonal antibody, in severe, uncontrolled asthma. In STRATOS 2, tralokinumab did not achieAlready a subscriber Login You have read all your…
The company applied today with the Swedish Medical and Pharmaceutical Agency for initiation of a phase I clinical trial of the contrast agent SpagoPix (SN132D) in patients with breast cancer. The study is planned to be conducted in Sweden at Uppsala University Hospital. The intention is to startAlready a subscriber Login…
